Selection of Filovirus Isolates for Vaccine Development Programs

MLA

Daniel N. Wolfe, et al. “Selection of Filovirus Isolates for Vaccine Development Programs.” Vaccines, vol. 9, no. 9, Aug. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....63b6e8e3d48692bd3d94302c07dd2a6d&authtype=sso&custid=ns315887.

APA

Daniel N. Wolfe, Larry A. Wolfraim, Michael Merchlinsky, Kimberly L. Taylor, Carol L. Sabourin, William C. Florence, & Lucy A. Ward. (2021). Selection of Filovirus Isolates for Vaccine Development Programs. Vaccines, 9(9).

Chicago

Daniel N. Wolfe, Larry A. Wolfraim, Michael Merchlinsky, Kimberly L. Taylor, Carol L. Sabourin, William C. Florence, and Lucy A. Ward. 2021. “Selection of Filovirus Isolates for Vaccine Development Programs.” Vaccines 9 (9). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....63b6e8e3d48692bd3d94302c07dd2a6d&authtype=sso&custid=ns315887.